Parkman Healthcare Partners LLC acquired a new stake in Qiagen (NYSE:QGEN – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 250,000 shares of the company’s stock, valued at approximately $10,858,000. Qiagen makes up about 1.5% of Parkman Healthcare Partners LLC’s portfolio, making the stock its […]